Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

What Does PNC-27 Dissolve In? Solvents Explained

Solubility behaviour is where compounds in this library differ most sharply from one another. For PNC-27, the determining factors are structural: membranolytic fusion peptide (32 residues): p53-derived domain + membrane-penetrating leader.

Membranolytic fusion peptide (32 residues): p53-derived domain + membrane-penetrating leaderCellular Longevity

Overview

Being membrane-active it can clump at high strengths — dilute from a stock instead of pushing concentration.

What PNC-27 actually is

A designed peptide studied only in the lab, in cell culture, for a striking trick: it latches onto HDM-2 on certain cancer cells and pokes holes in their outer membrane, breaking those cells apart while reportedly leaving healthy cells alone.

Supplied for laboratory research use only — not for human or animal use.

Research-grade PNC-27

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

How PNC-27 behaves in solution

An amphipathic, membrane-active peptide that can aggregate at higher concentrations. Prepare a stock and dilute into the assay system rather than working at the solubility limit; some cell-assay protocols use a DMSO stock.

Practical concentration range

Work below the aggregation point; higher concentrations offer no advantage and risk precipitation.

Suitable solvents, in order

Primary choiceSterile water for a stock, then dilution into assay buffer
Alternative 1DMSO for concentrated stocks in cell work
Alternative 2Bacteriostatic water for multi-use handling

Structural basis

PNC-27 is membranolytic fusion peptide (32 residues): p53-derived domain + membrane-penetrating leader. PNC-27 is a designed 32-residue peptide fusing a p53-derived region that binds HDM-2 with a membrane-penetrating leader sequence. It is studied strictly in vitro for a reported ability to form pores in the membranes of cancer cells that display HDM-2 at their surface, while reportedly sparing normal cells.

What PNC-27 is studied for

HDM-2 cell-surface targeting

Studied for binding HDM-2 displayed on the surface of certain cancer cells in vitro.

Membrane pore formation

Examined for forming transmembrane pores that lead to lysis of targeted cells in culture.

Selectivity in vitro

Investigated for a reported preference for tumour cells over normal cells in preclinical cell-culture models.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More PNC-27 reference

Solubility reference for other compounds

PNC-27 overview PNC-27 calculatorPNC-27 product details

PNC-27 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.